Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Core Laboratories's total inventories for the quarter that ended in Jun. 2026 was $58.0 Mil. Core Laboratories's average total inventories from the quarter that ended in Mar. 2026 to the quarter that ended in Jun. 2026 was $57.9 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Core Laboratories's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was $-3.94.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Core Laboratories's Days Inventory for the
three
months ended in Jun. 2026 was 50.20.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Core Laboratories's Inventory Turnover for the quarter that ended in Jun. 2026 was 1.82.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Core Laboratories's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.46.
Core Laboratories (NYSE:CLB) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Core Laboratories's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Core Laboratories's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Core Laboratories Total Inventories Related Terms
Core Laboratories Total Inventories Historical Data
* Premium members only.
The historical data trend for Core Laboratories's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Core Laboratories (CLB) has a Total Inventories of $58.0 Mil as of Jun. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Core Laboratories and its competitors.
Is Core Laboratories' Total Inventories too high?
Core Laboratories' current Total Inventories is $58.0 Mil. Overall, Core Laboratories has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Total Inventories compare to EROK and OIS?
Core Laboratories' Total Inventories of $58.0 Mil can be compared against companies in the Oil & Gas industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for an Oil & Gas company?
A good Total Inventories depends on the Oil & Gas industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Core Laboratories and its competitors. Core Laboratories's current Total Inventories is $58.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Core Laboratories (CLB) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.18, compared to a current price of $10.95 — trading 36.3% below its estimated fair value. The current Total Inventories is $58.0 Mil. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Core Laboratories (CLB), the current Total Inventories is $58.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of $10.95 is trading 36.3% below its estimated GF Value™ of $17.18.
GuruFocus considers Core Laboratories to be Significantly Undervalued.
Key valuation signals for CLB:
Total Inventories: $58.0 Mil
GF Value™: $17.18 vs. price of $10.95 (36.3% below fair value)
No single metric tells the full story. See the CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for CLB
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLB has been successfully added to your 
